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a b s t r a c t
The Autographa californica M nucleopolyhedrovirus (AcMNPV) sulfhydryl oxidase Ac92 is essential for
production of infectious virions. Ac92 also interacts with human p53 and enhances human p53-induced
apoptosis in insect cells, but it is not known whether any relationship exists between Ac92 and native
p53 homologs from insect hosts of AcMNPV. We found that Ac92 interacted with SfP53 from Spodoptera
frugiperda in infected cells and oxidized SfP53 in vitro. However, Ac92 did not interact with or oxidize a
mutant of SfP53 predicted to lack DNA binding. Silencing Sfp53 expression did not rescue the ability of an
ac92-knockout virus to produce infectious virus. Similarly, ac92 expression did not affect SfP53-
stimulated caspase activity or the localization of SfP53. Thus, although Ac92 binds to SfP53 during
AcMNPV replication and oxidizes SfP53 in vitro, we could not detect any effects of this interaction on
AcMNPV replication in cultured cells.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Disulﬁde bond formation is an important step in the matura-
tion of many proteins in eukaryotic and prokaryotic cells, since
disulﬁde bridges are often vital for protein folding and stability.
Disulﬁde bond formation is frequently catalyzed by sulfhydryl
oxidases while their reduction can be mediated by disulﬁde
reductases. The process of sulfhydyl oxidation in prokaryotes and
eukaryotes has functional and phenotypic parallels (Sevier and
Kaiser, 2002). Eukaryotes mediate redox balance using two main
sulfhydryl oxidase families present in two cellular organelles.
Proteins that are secreted or trafﬁcked through the mitochondrial
intermembrane space are oxidized in the endoplasmic reticulum
or mitochondrial intermembrane space, respectively (Fraga and
Ventura, 2012; Hakim and Fass, 2010; Herrmann et al., 2009). The
mitochondrial Erv (essential for respiration and viability) sulfhy-
dryl oxidase is essential for mitochondrial biogenesis, respiratory
chain function, and progression through the cell cycle. Erv-like
sulfhydryl oxidases are distributed widely among eukaryotic
species and many large double-stranded DNA viruses that assem-
ble in the cytoplasm of infected cells (Fass, 2008; Hakim and Fass,
2010).
Baculoviruses are double-stranded DNA viruses that mainly
infect insects and replicate in the nucleus of infected cells. During
the baculovirus replication cycle, two types of progeny virions are
produced, the budded virus (BV) and the occlusion-derived virus
(ODV). Erv family-like sulfhydryl oxidase homologs are present in
all sequenced baculovirus genomes (Rohrmann, 2011) and the
homolog encoded by the Autographa californica M nucleopolyhe-
drovirus (AcMNPV), Ac92 (P33), has been demonstrated to have
sulfhydryl oxidase activity (Long et al., 2009; Wu and Passarelli,
2010) and is essential for infectious budded virus production and
for the formation of multiply enveloped ODV (Nie et al., 2011;
Wu and Passarelli, 2010). Viruses with a deletion in ac92 or a
mutation in the sequence CXXC (Wu and Passarelli, 2010), a
sulfhydryl oxidase motif important for oxidation in cellular
enzymes (Fass, 2008), exhibited similar phenotypes, suggesting a
requirement for disulﬁde bond formation in the proper assembly
and propagation of AcMNPV virions. The structure of Ac92 revealed
that the arrangement of active-site cysteine residues and bound
ﬂavin adenine dinucleotide cofactor is similar to that observed in
other Erv family sulfhydryl oxidases (Hakim et al., 2011). Although
Ac92 is a functional sulfhydryl oxidase and its enzymatic activity is
essential for proper ODV formation and BV production, the target
substrate(s) of Ac92 during baculovirus infection is unknown.
A previous study showed that Ac92 interacted with the human
tumor suppressor protein p53 and enhanced p53-mediated apoptosis
when these proteins were co-expressed in insect cells (Prikhod'ko
et al., 1999). In both vertebrates and invertebrates, p53 is involved in
several cellular processes, including sequence-speciﬁc transcriptional
activation, cell cycle regulation, activation of DNA repair proteins, and
initiation of apoptosis when DNA damage is irreparable. Recently, the
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p53 homolog in Spodoptera frugiperda, SfP53, was characterized and its
role during baculovirus infection of Sf9 insect cells was studied.
Baculovirus infection stimulated a DNA damage response, as indicated
by increased accumulation of SfP53 protein and other criteria. Con-
sistent with this result, inhibition of the DNA damage response
thwarted an increase in SfP53 accumulation. However, silencing
Sfp53 using RNA interference did not affect baculovirus replication or
induction of apoptosis by a baculovirus lacking the anti-apoptotic gene
p35, suggesting that these processes are independent of SfP53 in Sf9
cells (Huang et al., 2011a, 2011b).
Many factors affect the stability of p53, including DNA damage or
other stress stimuli, interacting proteins (Lavin and Gueven, 2006), or
post-translational modiﬁcations such as site-speciﬁc phosphoryla-
tion, acetylation, ubiquitination (Bode and Dong, 2004), or redox
modiﬁcation of p53 cysteine residues (Kim et al., 2011). Since Ac92
interacts with human p53 when it is expressed in insect cells, it is
possible that it also interacts with SfP53, affecting the stability of
SfP53 or changing its redox state. However, the relationship between
Ac92 and p53 homologs from S. frugiperda or other insect hosts of
AcMNPV has not been investigated.
To characterize the relationship between Ac92 and SfP53, we
performed co-immunoprecipitation to assess interaction relation-
ships, determined protein localization during virus infection, and
examined the accumulation of SfP53 and Ac92 in the presence or
absence of each protein. Finally, we tested whether SfP53 was an
in vitro substrate for Ac92 sulfhydryl oxidation, and whether
expression of Ac92 affected the ability of SfP53 to induce caspase-
mediated apoptosis. Our results indicate that Ac92 can bind and
oxidize SfP53 in vitro, but we did not ﬁnd an obvious functional
relationship between Ac92 and SfP53 in Sf9 cells.
Results
Ac92 interacts with SfP53 in Sf9 cells
A previous study demonstrated that human p53 interacted with
AcMNPV Ac92 (P33) when p53 was expressed from a recombinant
baculovirus in SF-21 insect cells (Prikhod’ko et al., 1999). To test
whether SfP53, the P53 homolog in S. frugiperda, also interacts with
Fig. 1. Coimmunoprecipitation of Ac92 and SfP53. Sf9 cells were cotransfected with plasmids (A–D) or infected (E) with virus as indicated to the left. At 24 h p.t. or 48 h p.i.,
cells were collected and lysed for immunoprecipitation using the antibodies indicated above each lane. Transferred proteins were probed with the indicated antibodies at the
top. Input, input cell lysates; IP/Ctrl. IgG, control immunoprecipitation with mouse IgG; IP/anti-FLAG, immunoprecipitation with anti-FLAG antibody; IP/anti-HA,
immunoprecipitation with anti-HA antibody; IP/PI-serum, immunoprecipitation with SfP53 preimmune sera; IP/anti-SfP53, immunoprecipitation with SfP53 antisera.
Plasmid names: Flag-Ac92, phsFHORF92; HA-SfP53, pHA-SfP53; HA-SfP53-DBD, pHA-SfP53-DBD; Flag-Ac92M1, pFH-Ac92M1; and HA-SfP53-R252H, pHA-SfP53-R252H.
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Ac92, we performed co-immunoprecipitation experiments using
plasmids expressing full-length HA-tagged SfP53 or speciﬁc domains
or mutants of SfP53, and Flag-tagged Ac92. When HA-SfP53 and
Flag-Ac92 were co-expressed in Sf9 cells, Ac92 and SfP53 co-
immunoprecipitated, regardless of whether immunoprecipitation
was with anti-HA and detection with anti-FLAG, or vice versa
(Fig. 1A). Next, we used a plasmid that expressed the putative
SfP53 DNA binding domain (DBD; amino acids 71–272) to determine
if Ac92 interacted with this domain. This helps delineate the
interaction region and the possibility that Ac92 prevents DNA
binding of SfP53. Ac92 also co-immunoprecipitated with the SfP53
DNA binding domain (Fig. 1B). Mutation of cysteines 155 and 158 of
Ac92 (Ac92M1), which eliminate sulfhydryl oxidase activity (Wu and
Passarelli, 2010) did not affect the interaction between Ac92 and
SfP53 (Fig. 1C), indicating that the interaction spanned a larger
domain or involved another Ac92 domain. We note that although
SfP53 antiserum was raised against a His-tagged SfP53, this anti-
serum or anti-His serum could not immunoprecipitate the Flag-Ac92
protein (from phsFHORF92, data not shown) which is also His-
tagged. To test whether mutations within the SfP53 DBD affected
the interaction between Ac92 and SfP53, we constructed a plasmid
that expressed SfP53 with an arginine to histidine change at amino
acid 252. This change abolishes DNA binding in the Drosophila p53
ortholog (Brodsky et al., 2000). These two proteins were unable to
speciﬁcally co-immunoprecipitate; similar amounts of HA-SfP53-
R252H were non-speciﬁcally pulled down with anti-FLAG regardless
of the presence or absence of Flag-Ac92 (Fig. 1D).
The data presented thus far indicate that Ac92 and SfP53 expressed
from plasmids transfected into Sf9 cells co-immunoprecipitated, and
this interaction was abolished by a mutation in the SfP53 DBD.
To determine if endogenous SfP53 could interact with Ac92 expressed
during virus infection, we constructed a recombinant AcMNPV bac-
mid, Ac92FlagRep-PG, to express a Flag-tagged Ac92 under its natural
promoter during virus infection. Since the SfP53 antiserumwas raised
against HA–His-tagged SfP53 recombinant protein, it cross-reacts with
HA-tagged proteins, and so the virally expressed HA-tagged Ac92 was
immunoprecipitated by the anti-SfP53 sera. To circumvent this pro-
blem, we constructed a recombinant virus called Ac92FlagRep-PG,
where the Ac92 protein with a C-terminal Flag tag driven by the ac92
promoter was reintroduced into an ac92 deﬁcient background
(Fig. 2A).
Virus growth curves were performed to ensure that the
Ac92Flag could rescue infectious BV production in Ac92KO. Sf9
cells were infected with the indicated recombinant viruses at a
low multiplicity of infection (MOI) of 0.01 or a high MOI of 5 PFU/
cell. The recombinant viruses had similar BV production (Fig. 2B),
conﬁrming that Ac92Flag expressed from its own promoter in a
different genomic location could functionally rescue BV produc-
tion defects in Ac92KO. When the ability of Ac92Flag to interact
with endogenous SfP53 was tested, a positive interaction was
detected in reciprocal co-immunoprecipitation experiments
(Fig. 1E). This established that endogenous SfP53 interacts with
normal levels of Ac92 expressed during virus infection in Sf9 cells.
In vitro oxidation of SfP53 thiols by Ac92
Ac92 was shown to be a sulfhydryl oxidase based on its
homology to cellular and viral sulfhydryl oxidases, its ability to
Fig. 2. Construction of recombinant bacmids and analysis of BV production in Sf9 cells. (A) Schematic diagram of Ac92FlagRep-PG and Ac92GFP-PH showing polyhedrin
(polh) and enhanced green ﬂuorescence protein (egfp) inserted into the polh locus by Tn7-mediated transposition. (B) BV production measured by TCID50 endpoint dilution
assays. Titers were determined by TCID50 endpoint dilution from supernatants of cells infected with AcWT-PG, Ac92FlagRep-PG or Ac92GFP-PH at MOI of 0.01 or 5 PFU/cell
and collected at the designated time points.
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oxidize DTT or reduced thioredoxin, and its crystal structure (Fass,
2008; Long et al., 2009; Wu and Passarelli, 2010). Since Ac92 was
detected in a complex with SfP53 in infected cells, we asked
whether SfP53 could serve as a substrate of Ac92. SfP53 and the
SfP53 DNA binding mutant SfP53-R252H proteins were produced
in E. coli, partially puriﬁed (Fig. 3A), and tested as substrates for
Ac92 in vitro. Ac92 was able to oxidize SfP53 sulfhydryl groups in a
time-dependent manner and with similar oxidation efﬁciencies
between 5 and 120 min. However, SfP53-R252H, which does not
immunoprecipitate with Ac92, was not oxidized by Ac92 (Fig. 3B).
Ac92HAM1, an Ac92 mutant unable to oxidize thiols (Wu and
Passarelli, 2010), was used as the negative control to show back-
ground activity (Fig. 3B).
Silencing Sfp53 did not rescue Ac92KO-PG BV production
Since SfP53 is oxidized by Ac92 in vitro, we speculated that
oxidation of SfP53 may be necessary for efﬁcient virus replication.
Thus, in the absence of Ac92 in Ac92KO-PG, the reduced form of
SfP53 may adversely affect BV production. To test this hypothesis,
we silenced Sfp53 expression prior to transfection of Sf9 cells with
AcWT-PG or Ac92KO-PG bacmid DNA and monitored BV produc-
tion. Silencing of SfP53 was conﬁrmed by immunoblotting cell
lysates after dsRNA addition (Fig. 4A). BV produced after transfect-
ing cells with AcWT-PG (Wu and Passarelli, 2010) or Ac92KO-PG
DNA were collected to generate growth curves. Cells transfected
with AcWT-PG bacmid DNA revealed a steady increase in virus
Fig. 3. Protein puriﬁcation and sulfhydryl oxidase assay. (A) His-tagged SfP53 (left panel) or SfP53-R252H protein (right panel) was expressed in E. coli, partially puriﬁed, and
analyzed by SDS-PAGE followed by Coomassie Blue staining. Sup, supernatant; M, markers (B) Sulfhydryl oxidase assays were carried out with puriﬁed SfP53 or SfP53-R252H
as substrate and puriﬁed Ac92HA. Representative results of three independent repeats are shown. Ac92 cysteine mutant protein Ac92HAM1 was used as a negative control.
The measurement and calculation of free thiol groups is described in Materials and methods.
Fig. 4. Silencing of Sfp53 during transfection of Ac92KO-PG DNA does not rescue the BV production defect in Ac92KO-PG. (A) Sf9 cells were transfected with either control cat
or Sfp53 dsRNA, and 24 h p.t. transfected with Ac92KO-PG bacmid DNA. Cell lysates were prepared at the indicated times h p.t. and immunoblotted for SfP53. AcWT-PG DNA
was also transfected as a control. (B) Budded virus was collected and the titers were determined by TCID50 endpoint dilution. Bars show means and standard errors from
three independent experiments.
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production, as expected (Fig. 4B). However, no infectious BV was
produced in cells transfected with Ac92KO-PG bacmid DNA after
silencing Sfp53 or when the non-speciﬁc cat dsRNA was used
(Fig. 4B). Thus, reducing the levels of Sfp53 did not compensate for
the inactivation of Ac92.
Ac92 does not enhance SfP53-mediated apoptosis in Sf9 cells
Overexpression of SfP53 induces caspase activity and apoptosis
in Sf9 cells (Huang et al., 2011a). Since Ac92 interacts with and
oxidizes thiols in SfP53, we asked whether Ac92 affected SfP53-
mediated apoptosis. Expression of full-length SfP53 or the SfP53
DBD, pHA-SfP53-DBD, were able to stimulate similar levels of
caspase activity (Fig. 5, columns 2 and 3). Although the DNA
binding mutant, pHA-SfP53-R252H, was not signiﬁcantly different
from the full-length SfP53, it consistently stimulated reduced
levels of caspase activity (Fig. 5, compare columns 2 and 3 to 4).
Inhibition by the caspase inhibitor zVAD-FMK demonstrated assay
ﬁdelity (columns 5–7). Ac92 expression did not stimulate signiﬁ-
cant caspase activity on its own (columns 8 and 9), nor did it
stimulate HA-SfP53-mediated caspase activation above levels
induced by SfP53 alone or with an empty vector (Fig. 5, compare
column 11 with 10 or 2).
Fig. 5. Caspase activity measurement. Sf9 cells were (co)transfected with the
indicated plasmid(s). At 24 h p.t. cells were collected and the lysates were assayed
for caspase activity. Fluorescence intensity is shown relative to that of cells transfected
with pBlueScript II SK(þ) (BS). Bars indicate standard errors of three independent
experiments. Plasmid abbreviations are speciﬁed in the legend to Fig. 1.
Fig. 6. Localization of SfP53 and Ac92 by immunoﬂuorescence staining. Sf9 cells were mock- (mi) or virus-infected (AcWT-PG or Ac92GFP-PH), or transfected with the
indicated viral (Ac92KO-PG) or plasmid (pAc92GFP) DNA, and SfP53 and Ac92 were localized by confocal microscopy. TO-PRO-3 was used to stain nuclei of the cells (red).
SfP53 was detected by anti-SfP53 antisera (blue). (A) SfP53 localization was not affected by Ac92. GFP expression (green) is shown in virus-infected or viral DNA transfected
Sf9 cells. (B) Localization of SfP53 and Ac92 in the presence or absence of baculovirus infection. Ac92 was expressed as a C-terminal EGFP fusion and its localization detected
by visualizing GFP (green). The merge shows a merge of the TO-PRO-3, SfP53 and Ac92GFP images, and the bright ﬁeld merge includes the bright ﬁeld image in the merged
images. Arrows indicate occlusion bodies in the nucleus of infected cells.
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Ac92 does not affect the cellular localization of SfP53 and partially
co-localizes with SfP53 in Sf9 cells
The interaction between Ac92 and SfP53 after plasmid transfec-
tions and during virus infections suggests that at least some of Ac92
and SfP53 co-localize in cells. To conﬁrm this and determine whether
Ac92 expression could affect the localization of SfP53 in insect cells,
immunoﬂuorescence experiments were performed with anti-SfP53 in
plasmid-transfected or virus-infected cells. TO-PRO-3 (red color) was
used to visualize DNA in the nucleus, where viral DNA replicates
(Fig. 6). In mock-treated cells, SfP53 was localized throughout the
nucleus (Fig. 6A). However, in infected cells, SfP53mainly localized to a
central body within the nucleus, which may have been the virogenic
stroma. Localization of SfP53 was not affected by the presence (AcWT-
PG-infected) or absence (Ac92KO-PG DNA-transfected) of ac92 (blue
color, Fig. 6A), suggesting that Ac92 did not affect the localization of
SfP53 in virus-infected cells. AcWT-PG-infected or Ac92KO-PG DNA-
transfected cells were visualized by expression of GFP expressed from
the polyhedrin locus (green color, Fig. 6A).
Ac92 localization, visualized by expression of a fusion of Ac92-
GFP, was mainly observed in a punctate staining pattern in the
cytoplasm around the outside of the nucleus of pAc92GFP-
transfected cells. However, in cells infected with Ac92-GFP-PH,
Ac92-GFP was localized within the nucleus around the viral DNA
replication center (ring zone) (Fig. 6B), although more diffused
Ac92-GFP ﬂuorescence was observed throughout the nucleus.
Note the presence of occlusion bodies within the nucleus of the
cells in the lower bright ﬁeld image and coinciding with Ac92-GFP
localization (Fig. 6B, bright ﬁeld merge). Since Ac92-GFP was
mainly cytoplasmic in transfected cells and mainly nuclear in
infected cells, it is possible that another viral gene is necessary to
localize Ac92-GFP within the nucleus. These results indicate that
Ac92 and SfP53 only partially co-localized during infection; the
majority of Ac92 was around the inner periphery of the nucleus
and did not co-localize with SfP53.
Overexpression or silencing of Ac92 during virus infection
does not affect SfP53 accumulation
To determine whether expression of Ac92 affected SfP53
accumulation, we overexpressed Ac92 or silenced ac92 during
Fig. 7. Effects of Ac92 on the accumulation of SfP53. (A) Expression of Ac92 does not affect SfP53 levels. Sf9 cells were transfected with the indicated plasmids, and at 24 h p.t.,
cells were collected and lysates were immunoblotted with anti-SfP53 antisera to detect expression levels of SfP53, and with anti-FLAG to conﬁrm the expression of Ac92 or the
Ac92 cysteine mutant, Flag-Ac92M1. The asterisk indicates a protein band that can serve as a loading control. (B) Overexpression of Ac92 during baculovirus infection does not
affect SfP53. Sf9 cells were transfected with pHSGFP (GFP) as a negative control or phsFHORF92 (Flag-Ac92) and at 24 h p.t., cells were infected with Ac92HARep-PG. Cells were
collected and lysates were immunoblotted with anti-SfP53 antisera. Since anti-SfP53 antisera were raised against HA-tagged SfP53 recombinant protein, it also recognized
HA-tagged Ac92. (C) Silencing ac92 during baculovirus infection does not affect SfP53. Sf9 cells were transfected with either control cat or ac92 dsRNA, at 24 h p.t., cells were
infected with Ac92HARep-PG. Cell lysates were prepared at the indicated h p.i. or h p.t. and immunoblotted with anti-SfP53 antisera. The data shown are representative of three
independent experiments.
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virus infection. Sf9 cells were transfected with phsFHORF92 (Flag-
Ac92) or pFH-Ac92M1 (Flag-Ac92M1), expressing a functional or
non-functional Ac92, respectively, and the expression of endogen-
ous SfP53 was monitored by immunoblotting using SfP53 anti-
serum. No difference was observed in SfP53 levels between cells
transfected with control (pHSGFP) or Ac92-expressing plasmids
(phsFHORF92 and pFH-Ac92M1) (Fig. 7A). Next, to study the effect
of Ac92 overexpression or native expression during virus infection
on the accumulation of endogenous SfP53, Sf9 cells were trans-
fected with pHSGFP as a control or Flag-Ac92-expressing plasmid,
and at 24 h p.t., cells were infected with Ac92HARep-PG. Thus,
cells either expressed Ac92 from virus infection or overexpressed
it from virus-infected and plasmid-transfected cells. Cells were
collected at different time points and the expression level of SfP53
was determined by immunoblotting. Again, no obvious differences
were detected in SfP53 levels when Ac92 was overexpressed
during virus infection (Fig. 7B). The HA-tagged Ac92 expressed
from the Ac92HARep-PG recombinant virus was also detected
with SfP53 antiserum because anti-SfP53 was raised against an
HA-tagged SfP53 recombinant protein (Huang et al., 2011a)
(Fig. 6B).
The effect of silencing ac92 during virus infection on the
accumulation of endogenous SfP53 was also investigated. Sf9 cells
were transfected with ac92 dsRNA 24 h prior to infection with
Ac92HARep-PG. The expression of SfP53 in Sf9 cells was not
affected when ac92 was silenced during virus infection compared
to control cat dsRNA (Fig. 7C). Note that ac92 knockdown was also
conﬁrmed in the same immunoblot since the SfP53 antiserum also
recognized HA-tagged Ac92 (Fig. 7C).
Overexpression or silencing of SfP53 during virus infection
does not affect Ac92 accumulation
The effect of SfP53 expression on Ac92 accumulation was also
studied. SfP53 was overexpressed by transfection of pHA-SfP53, as
conﬁrmed by immunoblotting, but no obvious effects were
observed on the accumulation of Ac92 expressed from Ac92HA-
Rep-PG-infected cells compared to cells transfected with pHSGFP
as a negative control (Fig. 8A). Similarly, when SfP53 was silenced
with dsRNA during virus infection, Ac92 accumulation was not
affected (Fig. 8B). These results indicate that SfP53 and Ac92 did
not affect the expression of each other during virus infection.
Discussion
The Ac92 protein is a functional sulfhydryl oxidase that is
required for infectious BV production and for the formation of
multiply enveloped ODV (Nie et al., 2011; Wu and Passarelli, 2010).
Homologs of ac92 are found in all sequenced baculovirus genomes,
further emphasizing the importance of this gene in baculovirus
replication (Rohrmann, 2011). Previous studies revealed an asso-
ciation between Ac92 and the human p53 protein (Prikhod'ko
et al., 1999). In this report, we examined the relationship between
Ac92 and SfP53, the S. frugiperda p53 homolog.
Similar to other well characterized p53 homologs, SfP53 is
predicted to encode an activation domain, a central core sequence-
speciﬁc DNA binding domain, and a multifunctional C-terminal
domain (Huang et al., 2011a). A number of proteins interact with
the activation domain or the C-terminal domain of p53, including
general transcription factors, replication and repair proteins,
transcriptional activators, or kinases, but not many proteins appear
to bind to the p53 DNA binding domain (Ko and Prives, 1996; Lavin
and Gueven, 2006). In addition to cellular proteins, a few virally
encoded proteins associate with p53 (Ko and Prives, 1996), e.g., the
SV40 large T-antigen (Linzer and Levine, 1979), adenovirus E1b-
55-kDa (Sarnow et al., 1982), and human papilloma virus E6
(Werness et al., 1990).
Ac92 interacted with full-length SfP53 and the SfP53 DNA binding
domain (SfP53-DBD) in co-immunoprecipitations (Fig. 1A, B and E).
Fig. 8. Overexpression of SfP53 during baculovirus infection does not affect Ac92. (A) Sf9 cells were transfected with pHA-SfP53 (HA-SfP53) to overexpress SfP53 or pHSGFP
(GFP) as a negative control. At 24 h p.t., cells were infected with Ac92HARep-PG. Cells were collected and lysates were immunoblotted with anti-SfP53 antisera. (B) Silencing
Sfp53 during baculovirus infection does not affect Ac92. Sf9 cells were transfected with either control cat or Sfp53 dsRNA. At 24 h p.t., cells were infected with Ac92HARep-
PG. Cell lysates were prepared at the indicated times (in hours) post-infection (h p.i.) or post-transfection (h p.t.) and immunoblotted with anti-SfP53 antisera. The data
shown are representative of three independent experiments.
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We do not know if this complex includes other cellular or viral
proteins. The p53 DNA binding domain binds few reported proteins
(e.g., Tumor protein p53 binding proteins, TP53BP1 and TP53BP2
(Iwabuchi et al., 1994)), so it is possible that the virus uses Ac92 to
block binding of SfP53 to cellular proteins or to prevent its binding to
cellular DNA, inhibiting cellular transcriptional activation. In contrast,
Ac92 did not interact with SfP53-R252H, which is predicted to be a
DNA binding domain mutant based on homology to human and
Drosophila p53 (Fig. 1D). Interestingly, the Ac92 cysteine mutant,
Ac92M1, though unable to catalyze disulﬁde bond formation, was
able to interact with SfP53 (Fig. 1C), suggesting that the conformation
of the protein may not have been signiﬁcantly altered and/or that the
SfP53 cysteines are not involved in the interaction. In contrast, SfP53-
R252H, where only one amino acid in the DNA binding domain was
changed, was unable to interact with or be oxidized by Ac92.
Structural properties may have affected the interaction of SfP53
DNA binding domain and abolished the interaction of SfP53 with
Ac92. Curiously, the expression level of SfP53 DNA binding mutant
SfP53-R252H was consistently higher than that of the wild-type
SfP53 (data not shown). Some of the measured caspase activity
(Fig. 5, column 4) may be in part attributed to higher levels of protein
in the lysates. It is well known that the expression of human p53 is
maintained at a low level by ubiquitin-mediated degradation via the
E3 ubiquitin ligase MDM2. Although there are no detectable ortho-
logs of MDM2 in insects, the expression of SfP53 was also low in
uninfected Sf9 cells, but its accumulation increased following bacu-
lovirus infection or DNA damage (Huang et al., 2011b). Higher
accumulation of SfP53-R252H in uninfected Sf9 cells may suggest a
more stable and conformationally altered form or poor degradation
leading to increased accumulation. Thus, the ﬁnding that Ac92 could
not interact with or oxidize SfP53-R252H was consistent with this
hypothesis.
Oxidation of p53 thiol groups in cysteines is a post-translational
modiﬁcation (Hainaut and Milner, 1993; Rainwater et al., 1995). The
DNA binding activity of p53 can bemodulated bymetal chelators and
oxidizing agents. Thiol oxidation disrupts p53 conformation and
abolishes DNA binding; conversely, the reduced state of cysteine
residues favors p53 folding into its wild-type conformation and leads
to speciﬁc DNA binding (Hainaut and Milner, 1993). The roles of
individual cysteines in the regulation of p53 function have been
investigated by substitution of serine for each cysteine in murine
p53. Mutation of cysteines located in the zinc-binding region
markedly reduced in vitro DNA binding and blocked transcriptional
activation; while a mutation of non-zinc binding cysteines in the
DNA-binding domain, partially impaired p53 function (Rainwater
et al., 1995). In this study, Ac92 interacted with the SfP53 DNA
binding domain and catalyzed SfP53 cysteine oxidation, suggesting
Ac92 might inhibit SfP53 function by cysteine oxidation. However,
silencing SfP53 did not rescue BV production in Ac92 knockout virus.
Thus, the speciﬁc function of SfP53 during baculovirus replication
and the advantage of its oxidation for the virus remain elusive.
We tested if accumulation of either SfP53 or Ac92 was affected
in the presence or absence of the other gene. It has been shown
that overexpression of SfP53 in Sf9 cells induces caspase activity
(Huang et al., 2011a), but caspase activity was not enhanced by
Ac92 (Fig. 5). In contrast, Ac92 stimulated human p53-mediated
apoptosis in Sf9 cells (Prikhod’ko et al., 1999). SfP53 is a nuclear
protein like other p53 homologs. The localization of SfP53 at viral
replication centers was not affected by Ac92 (Fig. 6A). When Ac92
was expressed alone, it mainly localized in condensed centers
within the cytoplasm around the outside of the nucleus, while
expression during baculovirus infection included nuclear foci at
the ring zone of infected cells (Fig. 6B). Although p53 is a nuclear
protein, it might function outside the nucleus through protein–
protein interactions, e.g., p53 can translocate to the mitochondria
and interact with anti-apoptotic proteins such as BCL2 and BCL-XL
to induce apoptosis (Mihara et al., 2003). We do not know in
which cellular compartment Ac92 and SfP53 interact; they might
interact in the cytoplasm where there is a high concentration of
proteins or in the nucleus where multiple-ODV formation, a
process inﬂuenced by Ac92, takes place. Both the nucleus and
cytoplasm are reducing compartments and the oxidizing function
of Ac92 could serve as a functional switch.
Overexpression of Ac92 or silencing ac92 expression during
baculovirus infection did not affect the steady-state expression levels
of SfP53 (Fig. 7). We also investigated whether SfP53 affected Ac92
by overexpressing SfP53 or silencing Sfp53 during virus infection, and
found that the expression level of Ac92 was not affected (Fig. 8).
Overall, using the assays described, we could not detect any direct
effects between the two proteins during virus infection. This is not
necessarily surprising since it was conﬁrmed that SfP53 was not
responsible for the DNA damage response triggered during baculo-
virus infection and silencing of Sfp53 did not affect baculovirus
replication in Sf9 cells (Huang et al., 2011b). Although the role of
SfP53 during baculovirus replication is not clear, identifying the
targets of Ac92 may shed light into the functional requirement of
Ac92 during baculovirus replication. In this report, assays that
deﬁned a relationship between Ac92 and SfP53 were carried out
in vitro or using cell free assays. The correlation between Ac92 and
SfP53 in vivo was not clearly established in this cell line, but the
results may be different in other cell types. During a natural infection
of an insect, it is possible that the interaction of Sfp53 with Ac92 is
important in certain cell types that are not reﬂected in cultured Sf9
cells. Additionally in vitro and in vivo experimentations are required
to deﬁne more speciﬁc functions and establish any dependency or
correlation between these genes.
Materials and methods
Viruses, cell lines and bacterial strains
The Sf9 insect cell line, clonal isolate 9 from IPLB-Sf21-AE cells,
derived from the fall armyworm S. frugiperda, was purchased from
ATCC and cultured at 27 1C in TC-100 medium (Invitrogen)
supplemented with 10% fetal bovine serum (Atlanta Biologicals),
penicillin G (60 mg/ml), streptomycin sulfate (200 mg/ml), and
amphotericin B (0.5 mg/ml).
Construction of plasmids and recombinant AcMNPV bacmids
Plasmid pHA-SfP53 was constructed as previously described
(Huang et al., 2011a) in which SfP53 was HA-tagged at the
N terminus and expressed under control of the AcMNPV ie-1
promoter. To construct the plasmid pHA-SfP53-R252H, arginine
252 was changed to histidine as described (Chiu et al., 2008) using
primers Sfp5352FT (5′-GGTGCCCACGTGTGTGCCTGTCCTCGCCGG-
GACATGGTGA-3′), Sfp5353FS (5′-TGTCCTCGCCGGGACATGGTGA-3′),
Sfp5332RT (5′-GGCACACACGTGGGCACCCACTTTCTGACGTCCGTAGA-
CT-3′), and Sfp5333RS (5′-CACTTTCTGACGTCCGTAGACT-3′) and
pHA-SfP53 as the template. PCR products were digested with DpnI
(New England Biolabs) for 2 h and denatured at 99 1C for 3 min,
followed by annealing during two cycles of 65 1C for 5 min and 30 1C
for 15 min. Escherichia coli DH5α cells were transformed using the
PCR products. The mutation in the ﬁnal product pHA-SfP53-R252H
was conﬁrmed by DNA sequencing. To construct the plasmid pHA-
SfP53-DBD, containing the predicted SfP53 DNA binding domain
with an N terminus HA tag under control of the AcMNPV ie-1
promoter, primers Nco.Nde.HA.sfp53-aa71 (5′-CCATGGCACATAT
GTACCCATACGACGTCCCAGATTACGCCGGCCGACCGCCGCACTTTCCCTT
C-3′) and Sfp53.aa272.Nco (5′-TTATGCCATGGACTTGTAGACACCCTC-
GGCCGTCTC-3′) were used to amplify the SfP53 DNA binding domain
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(aa 71–272). The PCR product was cloned into pCR II vector
(Invitrogen) and the nucleotide sequence was veriﬁed. The resulting
plasmid was cut by NcoI to release HA-SfP53-DBD fragment and the
fragment was ligated to pGR09-5.5 (Huang et al., 2011a) to generate
the ﬁnal construct pHA-SfP53-DBD. The plasmid phsFHORF92
(Prikhod'ko et al., 1999), obtained from the plasmid collection of
Dr. Lois K. Miller, contains Ac92 with an N-terminal Flag tag
expressed under the control of the Drosophila heat shock protein
(hsp) 70 promoter. pFH-Ac92M1 was constructed as described (Chiu
et al., 2008). Brieﬂy, four primers Ac9255FT (5′-GCAGCCATGGCACGC-
GATCATTATATGAACGTCA-3′), Ac9256FS (5′-CGCGATCATTATATGA
ACGTC-3′), Ac9237RT (5′-TGCCATGGCTGCCTGTAGTATGAAAAATACG
TTG-3′), and Ac9238RS (5′-CTGTAGTATGAAAAATACGTTG-3′) were
used in PCR ampliﬁcations with phsFHORF92 as a template. PCR
products were treated with DpnI. The mutation in pFH-Ac92M1 was
conﬁrmed by DNA sequencing. To express an Ac92-C-terminal EGFP
(enhanced green ﬂorescent protein) fusion protein under the
AcMNPV ie-1 promoter, pAc92GFP, a plasmid with an N-terminal
Flag-tagged Ac92 was used as a template for PCR with primers
5′-GCTAGCGCCATGGACTACAAGGACGACGACGATGACAAAATACCGCT-
GACGCCGCTTTTTTCTC-3′ (with NcoI and NheI sites and a Flag tag)
and 5′–TTAGGCCATGGATTGCAAATTTAACAATTTTTTGTATTCTC-3′ (with
an NcoI site). PCR products were cloned into pCR II and the insert
sequenced. The Flag-Ac92 fragment was released by digesting with
NcoI and puriﬁed. Plasmid pEGFP (Pearson et al., 2000) was digested
with XhoI and SalI to remove a 1-kbp fragment from the 3′ regulatory
region and self-ligated. This construct was then digested with NcoI
and ligated with an NcoI-digested Flag-Ac92 fragment yielding the
ﬁnal construct pAc92GFP.
The plasmid pHis6-SfP53 (Huang et al., 2011a) contains the
SfP53 with a 6X his tag at the N terminus cloned into the pET28a
expression vector to express and purify SfP53. To express the SfP53
DNA binding mutant SfP53-R252H in E. coli, pET28a-SfP53-R252H
was constructed. The vector pET28a was digested by NdeI/HindIII
and the fragment gel-puriﬁed. pHA-SfP53-R252H was cut with
NdeI/HindIII and the HA-SfP53-R252H fragment was gel-puriﬁed
and ligated into pET28a digested with the same enzymes to
construct the expression plasmid pET28a-SfP53-R252H. pHSGFP
(Crouch and Passarelli, 2002) carries egfp under control of the
Drosophila hsp 70 promoter.
Recombinant bacmids AcWT-PG, Ac92KO-PG, and Ac92HARep-
PG were previously described (Wu and Passarelli, 2010). Brieﬂy,
AcWT-PG is an AcMNPV-based bacmid containing the polyhedrin
gene and its promoter and egfp under control of the AcMNPV ie-1
promoter. Ac92KO-PG is similar to AcWT-PG but ac92 has been
deleted. Ac92HARep-PG is based on Ac92KO-PG and contains a
C-terminally HA-tagged ac92 with the ac92 promoter in the
polyhedrin locus. Ac92FlagRep-PG and Ac92GFP-PH recombinant
bacmids were constructed by introducing ac92, a C terminus Flag-
tagged or as an EGFP C-terminal fusion, respectively, into the ac92
deletion bacmid background. Two primers, Ac92510 (5′-GAA-
GGCCTAATGCACATATGTCTTATAC-3′) and Ac92310 (5′-CGCTCTA-
GATTACTTATCGTCGTCATCCTTGTAATCTTGCAAATTTAACAATTTTTT-
GTA-3′) were designed to amplify a PCR product containing ac92
with a C-terminal Flag tag and its native promoter. The PCR
product was digested with StuI/XbaI and ligated into pFB-PG-pA
(Wu and Passarelli, 2010) to generate pFBPG-Ac92Flag. Two
primers, GFP5 (5′-TCTAGAGGCAAAGGAGAAGAACTT-3′) and GFP3
(5′-CTGCAGTTATTTGTATAGTTCATC-3′) were designed to amplify
egfp without the start codon from the template pFB1-PH-GFP (Wu
et al., 2006). The PCR fragment was cut with PstI/XbaI and ligated
into the pFB-PHR (Hu et al., 2010) to generate the plasmid pFB-
PHR-GFP. Primers Ac9252 (5′-GAGCTCAATGCACATATGTCTTATA-
C-3′) and Ac9231 (5′-GGCTCTAGATTGCAAATTTAACAATT-3′) were
designed to amplify a fragment that contained the ac92 promoter
and open reading frame without the stop codon and then the
fragment was cut with SacI/XbaI and ligated to pFB-PHR-GFP to
generate pFB-PHR-Ac92GFP. Electrocompetent E. coli DH10B cells
containing helper plasmid pMON7124 and the Ac92KO bacmid
(Wu and Passarelli, 2010) were transformed with the donor
plasmid pFBPG-Ac92Flag or pFB-PHR-Ac92GFP to generate the
Ac92FlagRep-PG or Ac92GFP-PH recombinant bacmids. Bacmid
DNA was isolated and successful transposition was conﬁrmed by
PCR. The correct recombinant bacmids were electroporated into
DH10B cells and screened for tetracycline sensitivity to ensure that
the isolated bacmids were free of helper plasmids. Bacmid DNA
was extracted and puriﬁed with QIAGEN Large-Construct Kit and
quantiﬁed by optical density.
Plasmid or bacmid DNA transfections and viral growth curve analysis
To transfect plasmid or bacmid DNA, DNAs were mixed with a
non-commercial liposome reagent and added to Sf9 cells as
previously described (Crouch and Passarelli, 2002). Cells were
incubated with the DNA/liposome mixture at 27 1C for 5 h and
then washed twice with TC-100 media, followed by addition of
TC-100 media containing 10% fetal bovine serum (designated as
the zero time point) and incubation at 27 1C.
To generate viral growth curves, Sf9 cells (1.0106 cells/
35 mm-diameter dish) were transfected with bacmid DNA as
described above. The supernatants of the transfected cells contain-
ing budded virions were collected at various time points to
determine titers by TCID50 end-point dilution assays (O’Reilly
et al., 1992) on Sf9 cells.
Co-immunoprecipitation assays
Co-immunoprecipitations were done as previously described
(Lehiy et al., 2013). Sf9 cells in 60-mm-diameter culture dishes
were transfected as described above with 5 μg of the indicated
plasmids expressing Flag- or HA-tagged genes. At 20 h post-
transfection (p.t.), cells were heat-shocked for 30 min at 42 1C
and harvested after 4 h. Alternatively, Sf9 cells in 60-mm-diameter
culture dishes were infected with Ac92FlagRep-PG virus at a MOI
of 5 PFU/cell and harvested at 48 h p.i. Transfected or infected cells
were pelleted at 2000 g for 3 min and lysed with NP-40 IP/lysis
buffer (50 mM Tris–HCl, pH 8.0; 150 mM NaCl; 1 mM EDTA;
1% NP-40) and two cycles of freeze-thawing. The lysate was
clariﬁed by centrifugation at 10,000 g for 5 min and precleared
by adding 50 μl of a 50% slurry of protein G beads (Sigma),
followed by incubation at 4 1C for 1 h with rolling. The supernatant
was then transferred to a new microcentrifuge tube and mixed
with the indicated antibody. After incubation at 4 1C for 3 h with
rolling, 50 μl of a 50% slurry of protein G beads was added to the
mixture and incubated for another 1 h at 4 1C with rolling. The
beads were collected by centrifugation and washed ﬁve times with
IP/lysis buffer for 15 min each. Following addition of 25 μl of 2
Protein Loading Buffer (PLB, 0.25 M Tris–Cl, pH 6.8, 4% SDS, 20%
glycerol, 10% 2-mercaptoethanol and 0.02% bromophenol blue),
the samples were heated at 100 1C for 5 min. Samples were
immediately analyzed by immunoblotting or stored at 20 1C
until use.
Immunoblotting
Cells were collected and washed with phosphate-buffered
saline (PBS), pH 6.2 (Potter and Miller, 1980), resuspended in PBS
with an equal volume of 2 PLB, and incubated at 100 1C for
5 min. Protein samples were resolved by SDS-12% PAGE, trans-
ferred onto a PVDF membrane (MILLIPORE), and probed with one
of the following primary antibodies: (i) mouse monoclonal anti-
HA-HRP antibody (Cell Signaling); (ii) mouse monoclonal anti-
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FLAG antibody (Sigma); or (iii) rabbit polyclonal antisera raised
against SfP53 (Huang et al., 2011a), followed by incubation with
horse radish peroxidase-conjugated secondary antibodies (Sigma),
as needed. Blots were developed using SuperSignal West Pico
Chemiluminescent substrate (Pierce) and exposed to X-ray ﬁlm.
Protein puriﬁcation and sulfhydryl oxidase activity assays
His-tagged SfP53 or SfP53-R252H protein was produced from
plasmid pHis6-Sfp53 or pET28a-SfP53-R252H, respectively, in
E. coli strain BL21, using protein expression and puriﬁcation
methods as previously described (Wu and Passarelli, 2010). Pur-
iﬁed proteins were stored at 80 1C and used as substrates for
sulfhydryl oxidase activity. Sulfhydryl oxidase activity assays were
carried out as previously described (Long et al., 2009; Wu and
Passarelli, 2010). Brieﬂy, puriﬁed SfP53 or SfP53-R252H protein
was incubated with Ac92HA or Ac92HAM1 protein at 37 1C, and at
designated time points, aliquots were mixed with Ellman's reagent
(5′,5′-dithio-bis(2-nitrobenzoic acid, DTNB, Sigma) and thiol con-
tent was measured by absorbance at 412 nm, calculating an
extinction coefﬁcient of 13.6 mM1 cm1.
Gene silencing by RNA interference (RNAi)
RNAi was performed as previously described (Huang et al.,
2011b). Full-length open reading frame sequences were used as
templates for PCR, with the T7 promoter sequence TAATACGACT-
CACTATAGGG added at each 5′ end. Primers T7-CAT-dsRNA-F
(5′-TAATACGACTCACTATAGGGTATCCCAATGGCATCGTAAAGAACA-3′)
and T7-CAT-dsRNA-R (5′-TAATACGACTCACTATAGGGACAAACGGCAT-
GATGAACCTGAAT-3′) were used to amplify chloramphenicol acetyl
transferase (cat) template; primers T7-Ac92-dsRNA-F (5′-TAATACGA-
CTCACTATAGGGACTTATACCATTTTGCGTGTTTGAT-3′) and T7-Ac92-
dsRNA-R (5′-TAATACGACTCACTATAGGGATCGTTAATGTGGTTGTGAA
AAGTC-3′) were used to amplify ac92 template; primers T7-Sfp53-
dsRNA-F (5′-TAATACGACTCACTATAGGGATCGTTCACCAGGCGGGCTA
CC-3′) and T7-Sfp53-dsRNA-R (5′-TAATACGACTCACTATAGGGCCATG
TCCACGTTCCCGCAGTAGT-3′) were used to amplify Sfp53 template.
These templates were used to produce double stranded RNAs
(dsRNAs) by in vitro transcription using the AmpliScribe T7 High
Yield Transcription Kit (Epicentre), according to the protocol of the
manufacturer. dsRNA (150 μg) was delivered into Sf9 cells by
transfection to silence expression of ac92 or Sfp53, with cat dsRNA
used as a negative control.
Caspase activity
Sf9 cells were seeded in 35-mm-diameter culture dishes and
transfected with 3 μg of the indicated plasmids. Cells were heat-
shocked at 20 h p.t. to increase hsp70-Ac92 expression and were
collected 4 h after heat shock. Caspase activity was measured
using the mammalian caspase-3 substrate N-acetyl-Asp-Glu-Val-
Asp-(7-amino-4-triﬂuoromethylcoumarin) (DEVD-AFC; MP Bio-
medicals) as described previously (Wang et al., 2008). To inhibit
caspase activity, the caspase inhibitor zVAD-FMK (MP Biomedi-
cals) was added at a ﬁnal concentration of 20 μM.
Immunoﬂuorescence
Sf9 cells (1106) were seeded on coverslips in 35-mm-
diameter culture dishes and transfected with 3 μg of pAc92GFP
plasmid, with 1 μg of Ac92KO-PG bacmid DNA, or infected with
AcWT-PG or Ac92GFP-PH recombinant virus at an MOI of 1 PFU/
cell. At 24 h p.t. or p.i., the supernatant was removed and the cells
were washed twice with PBS, pH 6.2 (Potter and Miller, 1980), and
ﬁxed in 2.5% formaldehyde in PBS for 10 min at room temperature
(RT). The ﬁxed cells were washed three times in PBS for 5 min per
wash, followed by permeabilization in 0.1% NP-40 (Sigma) in PBS
for 10 min at RT. Cells were washed three times in PBS for 5 min
per wash before incubation with blocking buffer (5% BSA, 0.3%
Triton-100 in PBS) for 1 h at RT, followed by incubation with SfP53
anti-sera (1:500) in PBS with 1% BSA, 0.3% Triton X-100 overnight
at 4 1C. Cells were washed three times in blocking buffer for 5 min
each, followed by 1 h incubation with an Alexa Fluor 555-
conjugated goat anti-rabbit antibody (1:1000) in the dark at RT.
Cells were washed three times for 5 min each in PBS, followed by
incubation with 1 μM TO-PRO-3 (Invitrogen) in PBS for 15 min at
RT. The cells were subsequently washed three times for 10 min
each in PBS. Coverslips were mounted on a glass slide with
Fluoromount-G (SouthernBiotech) and stored at 4 1C in the dark
until examined with a Carl Zeiss LSM 5 Pascal Laser Scanning
Confocal Microscope.
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